Drug Chatter -- Tracking biopharma stock chatter

Profile for Agios Pharmaceuticals, Inc. (AGIO)

« Back to company index

AGIO Chatter Timeline

Stock Ticker for AGIO

Most Active Tweeters for AGIO

UserTweets
@filingBot 8
@intercooleronli 7
@CFinancialNews 7
@TickerReport 6
@dailypoliticaln 6

Recent Tweets for AGIO

adrianamale @adrianamale
RT @jordixiol: Enasidenib inhibits mutant form of IDH2 that is only found in cancer,but $CELG $AGIO are testing it in cirrhotic pts https:/…
September 25th 2017, 4:09pm
jordixiol @jordixiol
Enasidenib inhibits mutant form of IDH2 that is only found in cancer,but $CELG $AGIO are testing it in cirrhotic pts https://t.co/US8PZSuqz9
September 25th 2017, 3:09pm
deankrauss @deankrauss
Looks like Ivosidenib as well $AGIO $CELG https://t.co/lxA3mO1j2T https://t.co/Gos2jC3MF3
September 25th 2017, 1:09pm
SleekMoneycom @SleekMoneycom
Agios Pharmaceuticals, Inc. $AGIO Director Sells $65,470.00 in Stock https://t.co/1vRDfs6oRV
September 25th 2017, 9:09am
windham_kathryn @windham_kathryn
Sectoral Asset Management Upped By $3.69 Million Its Agios Pharmaceuticals $AGIO Position ...
September 24th 2017, 11:09am
WKRBNews @WKRBNews
Agios Pharmaceuticals, Inc. $AGIO Holdings Raised by Profund Advisors LLC https://t.co/LePSpx7F3T
September 24th 2017, 9:09am
dailymailtimes @dailymailtimes
Agios Pharmaceuticals, Inc. $AGIO Holdings Raised by Profund Advisors LLC https://t.co/uxf6357GZ2
September 24th 2017, 9:09am
midetimes @midetimes
Agios Pharmaceuticals, Inc. $AGIO Holdings Raised by Profund Advisors LLC https://t.co/VHdXH7ChVE
September 24th 2017, 9:09am
dailypoliticaln @dailypoliticaln
Agios Pharmaceuticals, Inc. $AGIO Holdings Raised by Profund Advisors LLC https://t.co/kd4IY9BRq6
September 24th 2017, 9:09am
storminvestor @storminvestor
ARK Investment Management LLC Buys 4,267 Shares of Agios Pharmaceuticals, Inc. $AGIO https://t.co/zOcUjpO6sA
September 23rd 2017, 10:09am
SPNewsAnalysis @SPNewsAnalysis
ARK Investment Management LLC Buys 4,267 Shares of Agios Pharmaceuticals, Inc. $AGIO https://t.co/oRw6FbnRr7
September 23rd 2017, 10:09am
dailypoliticaln @dailypoliticaln
Agios Pharmaceuticals, Inc. $AGIO CEO Sells $2,349,200.00 in Stock https://t.co/uztlwZwCn0
September 23rd 2017, 5:09am
WKRBNews @WKRBNews
Agios Pharmaceuticals, Inc. $AGIO CEO Sells $2,349,200.00 in Stock https://t.co/BAc9LLabj2
September 23rd 2017, 5:09am
dailymailtimes @dailymailtimes
Agios Pharmaceuticals, Inc. $AGIO CEO Sells $2,349,200.00 in Stock https://t.co/XN8rNyBIji
September 23rd 2017, 5:09am
midetimes @midetimes
Agios Pharmaceuticals, Inc. $AGIO CEO Sells $2,349,200.00 in Stock https://t.co/N9rSRuC1wx
September 23rd 2017, 5:09am
WatchlistN @WatchlistN
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Agios Pharmaceuticals $AGIO Share Price https://t.co/euhS0qPG3D
September 23rd 2017, 4:09am
midetimes @midetimes
BB Biotech AG Has $147.64 Million Stake in Agios Pharmaceuticals, Inc. $AGIO https://t.co/ZFngyjUV68
September 22nd 2017, 12:09pm
dailypoliticaln @dailypoliticaln
BB Biotech AG Has $147.64 Million Stake in Agios Pharmaceuticals, Inc. $AGIO https://t.co/sg0eGPFlyi
September 22nd 2017, 12:09pm
WKRBNews @WKRBNews
BB Biotech AG Has $147.64 Million Stake in Agios Pharmaceuticals, Inc. $AGIO https://t.co/gEKLOLGfpz
September 22nd 2017, 12:09pm
dailymailtimes @dailymailtimes
BB Biotech AG Has $147.64 Million Stake in Agios Pharmaceuticals, Inc. $AGIO https://t.co/hWRLiiNQ2e
September 22nd 2017, 12:09pm
ZolmaxNews @ZolmaxNews
David P. Schenkein Sells 35,000 Shares of Agios Pharmaceuticals, Inc. $AGIO Stock https://t.co/xaSFxcFm5H
September 22nd 2017, 5:09am
TickerReport @TickerReport
Agios Pharmaceuticals, Inc. $AGIO Stock Rating Reaffirmed by J P Morgan Chase & Co https://t.co/MQQOKEynN9
September 22nd 2017, 3:09am
TickerReport @TickerReport
Agios Pharmaceuticals, Inc. $AGIO Stock Rating Reaffirmed by J P Morgan Chase & Co https://t.co/KDjVNi8Otx
September 22nd 2017, 3:09am
emq_news @emq_news
Agios Pharmaceuticals, Inc. $AGIO Stock Rating Reaffirmed by J P Morgan Chase & Co https://t.co/GdcOXOWRsp
September 22nd 2017, 3:09am
SleekMoneycom @SleekMoneycom
Royal Bank Of Canada Initiates Coverage on Agios Pharmaceuticals, Inc. $AGIO https://t.co/DqrPes9hsz
September 21st 2017, 5:09pm
dakotafinancial @dakotafinancial
Agios Pharmaceuticals, Inc. $AGIO CEO David P. Schenkein Sells 35,000 Shares of Stock https://t.co/S4zRFvxuQA
September 21st 2017, 2:09pm
IRAMarketReport @IRAMarketReport
J P Morgan Chase & Co Reaffirms “Buy” Rating for Agios Pharmaceuticals, Inc. $AGIO https://t.co/8tZQPB2FfX
September 21st 2017, 4:09am
chaffeybreeze @chaffeybreeze
J P Morgan Chase & Co Reaffirms “Buy” Rating for Agios Pharmaceuticals, Inc. $AGIO https://t.co/F7jqktBr3O
September 21st 2017, 4:09am
SleekMoneycom @SleekMoneycom
Scott Biller Sells 15,000 Shares of Agios Pharmaceuticals, Inc. $AGIO Stock https://t.co/v4RW7sT1qp
September 20th 2017, 7:09pm
7LadyQ @7LadyQ
$AGIO Agios Pharmaceuticals Inc's Chief Executive Officer just disposed of 500 shares
September 20th 2017, 4:09pm
InsiderAlertsIA @InsiderAlertsIA
$AGIO: New Insider Filing on Chief Executive Officer DAVID P SCHENKEIN: https://t.co/GK6TflfPWU
September 20th 2017, 4:09pm
confcalltran @confcalltran
Agios Pharmaceuticals Inc's Chief Executive Officer just disposed of 500 shares https://t.co/uNyvhRvdkK $AGIO
September 20th 2017, 4:09pm
StockTexts @StockTexts
$AGIO Agios Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/KfwCiMThTl
September 20th 2017, 4:09pm
filingBot @filingBot
@Kastri7X there is a new form 4 filing for $AGIO https://t.co/dscKZNIaTW Spread the word!
September 20th 2017, 4:09pm
filingBot @filingBot
@altafmubaraki there is a new form 4 filing for $AGIO https://t.co/dscKZNIaTW Please RT.
September 20th 2017, 4:09pm
WatchlistN @WatchlistN
Agios Pharmaceuticals, Inc. $AGIO Stock Rating Reaffirmed by J P Morgan Chase & Co https://t.co/jJ1fPI7HuX
September 20th 2017, 5:09am
finboxio @finboxio
Agios Pharmaceuticals, $AGIO scores a 2 via Piotroski's F-Score... Yikes https://t.co/ygVcvuJgbo https://t.co/wkPZ1lnZlE
September 19th 2017, 7:09pm
Jake132013 @Jake132013
$AGIO Agios Pharmaceutical 66.90 Had 85,509 1 Month Highs. AGIO Last price 66.90 Last change +0.04 +0.06%. https://t.co/PRL4FiPQHn
September 19th 2017, 11:09am
CFinancialNews @CFinancialNews
J P Morgan Chase & Co Reaffirms “Buy” Rating for Agios Pharmaceuticals, Inc. $AGIO https://t.co/3pgdEhYh9c
September 18th 2017, 11:09pm
intercooleronli @intercooleronli
J P Morgan Chase & Co Reaffirms “Buy” Rating for Agios Pharmaceuticals, Inc. $AGIO https://t.co/CqGMoqDFwV
September 18th 2017, 11:09pm
marketexclusive @marketexclusive
Analyst Activity – J P Morgan Chase & Co Reiterates Buy on Agios Pharmaceuticals (NASDAQ:AGIO) https://t.co/oiqPR4Jnk6 $AGIO
September 18th 2017, 8:09pm
allincapital @allincapital
monthly $AGIO https://t.co/ltrdojY7MG
September 18th 2017, 12:09pm
iHangout2 @iHangout2
Jake13: Xtremepicks Alerts: $AGIO Agios Pharmaceutical 67.11 Had 196,903 1 https://t.co/m0binBBDMZ #InvestorsHangout
September 18th 2017, 12:09pm
Jake132013 @Jake132013
$AGIO Agios Pharmaceutical 67.11 Had 196,903 1 Month Highs. AGIO Last price 67.11 Last change +0.68 +1.02%. https://t.co/pGtTKo7H5u
September 18th 2017, 11:09am
stocknewsdotcom @stocknewsdotcom
$AGIO JPMorgan reiterates Overweight rating, $76 PT https://t.co/QM5jxLMg7p
September 18th 2017, 10:09am
WKRBNews @WKRBNews
Agios Pharmaceuticals, Inc. $AGIO Director Sells $65,470.00 in Stock https://t.co/vi4DJptkpi
September 18th 2017, 9:09am
midetimes @midetimes
Agios Pharmaceuticals, Inc. $AGIO Director Sells $65,470.00 in Stock https://t.co/AieLUSSYSw
September 18th 2017, 9:09am
dailypoliticaln @dailypoliticaln
Agios Pharmaceuticals, Inc. $AGIO Director Sells $65,470.00 in Stock https://t.co/iT0nBePFsm
September 18th 2017, 9:09am
TickerReport @TickerReport
Eaton Vance Management Has $2,824,000 Holdings in Agios Pharmaceuticals, Inc. $AGIO https://t.co/nDMUHXmD9k
September 18th 2017, 8:09am
emq_news @emq_news
Eaton Vance Management Has $2,824,000 Holdings in Agios Pharmaceuticals, Inc. $AGIO https://t.co/NOh2xg2i60
September 18th 2017, 8:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.